Rallybio Corp held its annual shareholder meeting on May 13, 2025, where Martin W. Mackay and Paula Soteropoulos were elected as Class I directors for terms ending in 2028, and the appointment of Deloitte and Touche LLP as the company's auditor was ratified by the shareholders.